Table 1 Baseline characteristics of TBM patients and control children
Patient | PPD Status | MTB detected by | Symptomatic Improvement following Therapy | ||
|---|---|---|---|---|---|
PCR | CSF Culture | CSF AFB Smear | |||
1 | Negative | + | + | + | + |
2 | Negative | + | + | + | + |
3 | Negative | + | − | − | + |
4 | Positive | + | − | − | + |
5 | Positive | − | − | − | + |
6 | Positive | − | − | − | + |
Controls | Diagnosis | ||||
7 | Congenital hydrocephalus | ||||
8 | Congenital hydrocephalus | ||||
9 | Glioma | ||||
10 | Idiopathic epilepsy | ||||
11 | No neurological disease | ||||
12 | Kawasaki disease with meningitis | ||||
13 | No neurological disease | ||||